Application 212470
- Type
- ANDA
- Sponsor
- JUBILANT GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUMETANIDE | BUMETANIDE | TABLET;ORAL | 0.5MG | No | No |
| 002 | BUMETANIDE | BUMETANIDE | TABLET;ORAL | 1MG | No | No |
| 003 | BUMETANIDE | BUMETANIDE | TABLET;ORAL | 2MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212470-001 | BUMETANIDE | BUMETANIDE | 0.5MG | TABLET / ORAL | AB | 2025-08-05 | |
| A212470-002 | BUMETANIDE | BUMETANIDE | 1MG | TABLET / ORAL | AB | 2025-08-05 | |
| A212470-003 | BUMETANIDE | BUMETANIDE | 2MG | TABLET / ORAL | AB | 2025-08-05 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212470-001 | AB |
| A212470-002 | AB |
| A212470-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A212470-001 | BUMETANIDE | 0.5MG | TABLET / ORAL | AB | 2025-08-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212470-002 | BUMETANIDE | 1MG | TABLET / ORAL | AB | 2025-08-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212470-003 | BUMETANIDE | 2MG | TABLET / ORAL | AB | 2025-08-05 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A212470-001 | BUMETANIDE | 0.5MG | TABLET / ORAL | AB | 2025-08-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212470-002 | BUMETANIDE | 1MG | TABLET / ORAL | AB | 2025-08-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212470-003 | BUMETANIDE | 2MG | TABLET / ORAL | AB | 2025-08-05 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212470-001 | BUMETANIDE | 0.5MG | TABLET / ORAL | AB | 2025-08-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212470-002 | BUMETANIDE | 1MG | TABLET / ORAL | AB | 2025-08-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212470-003 | BUMETANIDE | 2MG | TABLET / ORAL | AB | 2025-08-05 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212470-001 | BUMETANIDE | 0.5MG | TABLET / ORAL | AB | 2025-08-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212470-002 | BUMETANIDE | 1MG | TABLET / ORAL | AB | 2025-08-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212470-003 | BUMETANIDE | 2MG | TABLET / ORAL | AB | 2025-08-05 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212470-001 | BUMETANIDE | 0.5MG | TABLET / ORAL | AB | 2025-08-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212470-002 | BUMETANIDE | 1MG | TABLET / ORAL | AB | 2025-08-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212470-003 | BUMETANIDE | 2MG | TABLET / ORAL | AB | 2025-08-05 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212470-001 | BUMETANIDE | 0.5MG | TABLET / ORAL | AB | 2025-08-05 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212470-002 | BUMETANIDE | 1MG | TABLET / ORAL | AB | 2025-08-05 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212470-003 | BUMETANIDE | 2MG | TABLET / ORAL | AB | 2025-08-05 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A212470-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212470-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212470-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A212470-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A212470-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A212470-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A212470-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212470-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212470-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212470-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212470-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212470-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A212470-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212470-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212470-003 | AB | 1 | 6a471c1ec25d… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212470-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212470-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212470-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| bumetanide | BUMETANIDE | Zydus Pharmaceuticals (USA) Inc. | 525138cd-832a-41d0-84b0-83921b12bd2a | 2023-12-05 | Boxed warning, Warnings, Adverse reactions | bumetanide BUMETANIDE |
| bumetanide | BUMETANIDE | Zydus Lifesciences Limited | 82eb62ca-c32b-4ff8-9f71-43219b240480 | 2023-12-05 | Boxed warning, Warnings, Adverse reactions | bumetanide BUMETANIDE |
| bumetanide | BUMETANIDE | A-S Medication Solutions | cf29e436-b630-4b03-bb9b-9267ae77dc00 | 2023-11-01 | Boxed warning, Warnings, Adverse reactions | bumetanide BUMETANIDE |
| Bumetanide | BUMETANIDE | Sandoz Inc | 05cb961d-ac33-4bcf-b04e-411e496c43c1 | 2023-06-30 | Boxed warning, Warnings, Adverse reactions | Bumetanide BUMETANIDE |
| Bumetanide | BUMETANIDE | Civica, Inc. | 308c690f-c2bd-4c32-8728-42ec95425f77 | 2023-04-07 | Boxed warning, Warnings, Adverse reactions | Bumetanide BUMETANIDE |
| Bumetanide | BUMETANIDE | A-S Medication Solutions | 7f9dccf8-37ff-454b-9d55-7f1d631c8483 | 2023-01-25 | Boxed warning, Warnings, Adverse reactions | Bumetanide BUMETANIDE |
| Bumetanide | BUMETANIDE | GLENMARK PHARMACEUTICALS INC., USA | 680563fe-5d3a-49bc-86a5-740bda2acebe | 2023-01-09 | Boxed warning, Warnings, Adverse reactions | Bumetanide BUMETANIDE |
| Bumetanide | BUMETANIDE | A-S Medication Solutions | f6ff0d37-c67d-4b9f-8b62-5deda9783c28 | 2023-01-05 | Boxed warning, Warnings, Adverse reactions | Bumetanide BUMETANIDE |
| Bumetanide | BUMETANIDE | A-S Medication Solutions | 8bed63fb-91ec-4132-ac0a-16c4c6f58d95 | 2023-01-03 | Boxed warning, Warnings, Adverse reactions | Bumetanide BUMETANIDE |
| Bumetanide | BUMETANIDE | Fresenius Kabi USA, LLC | a007f3aa-3977-4be3-a9a2-db3d458bca58 | 2022-09-19 | Boxed warning, Warnings, Adverse reactions | Bumetanide BUMETANIDE |
| Bumetanide | BUMETANIDE | Novadoz Pharmaceuticals LLC | 387edfd4-be85-41cd-8a6d-14e6a022b5a9 | 2022-08-09 | Boxed warning, Warnings, Adverse reactions | Bumetanide BUMETANIDE |
| Bumetanide | BUMETANIDE | Gland Pharma Limited | 4d1ed6b2-c410-4f52-9b8a-aa256c37089e | 2022-06-01 | Boxed warning, Warnings, Adverse reactions | Bumetanide BUMETANIDE |
| Bumetanide | BUMETANIDE | Aphena Pharma Solutions - Tennessee, LLC | 7e47e7b1-d28a-4e12-882f-cf193b7f2697 | 2019-09-30 | Boxed warning, Warnings, Adverse reactions | Bumetanide BUMETANIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.